C-Path

Filter by Category

All Annual Meetings Blog Events Newsletters Podcasts Posters Publications Webinars Workshops

Filter by Program

Filter by Date

May 18, 2021

C-Path Request for Proposal for External Communications

Critical Path Institute (C-Path) is seeking a proposal, including timelines and budget, for external marketing, communications, pu

April 6, 2021

C-Path Welcomes Dr. Ramona Belfiore Oshan as D-RSC Associate Director

C-Path is pleased to welcome Ramona Belfiore Oshan, Ph.D., as the new Associate Director for its Duchenne Regulatory Science

March 31, 2021

Introducing Dr. Alexandre Bétourné, RDCA-DAP Scientific Director

C-Path is pleased to welcome Alexandre Bétourné, PhD, PharmD, as its new Scientific Director for the Rare Disease Cures Accelera

July 30, 2020

C-Path Partners with CHDR to Expand Global Collaborations

The Critical Path Institute and the Centre for Human Drug Research (CHDR) have joined forces to expand global collaborations for b

January 4, 2019

At the IBD Biomarker Summit, Hosted by the Crohn’s & Colitis Foundation, C-Path Shares the Case for formation of an IBD Biomarker Consortium

At the IBD Biomarkers Summit, hosted by the Crohn’s & Colitis Foundation on October 17-18, 2018, in Newark, N.J., Critical P

November 8, 2018

Profiles in Business with Tucson Metro Chamber

C-Path President and CEO Martha Brumfield, Ph.D., talks about today’s drug discovery process, C-Path’s global impact a

May 7, 2018

C-Path Receives COA Qualification from FDA for the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ)

TUCSON, Ariz. – May 7, 2018 — Critical Path Institute‘s (C-Path) Patient-Reported Outcome (PRO) Consortium annou

April 26, 2018

CPTR Newsletter – April 2018

CPTR Newsletter – April 2018 In this issue: ReSeqTB to be Adopted for WHO Surveillance of Drug-Resistant TB New Collabora

April 16, 2018

Helmsley Charitable Trust Awards Critical Path Institute a Grant to Focus on Crohn’s Disease Biomarkers

Tucson, AZ, and New York, NY – April 16, 2018 — The Leona M. and Harry B. Helmsley Charitable Trust has awarded Critical Path

February 12, 2018

Tucson-based Critical Path Institute emerging as top drug-research organization

President and CEO Dr. Martha Brumfield was recently interviewed by the Arizona Daily Star for a profile on C-Path published Februa

Previous23 4 Next